F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comJohnson Pharmacare Ltd is a micro-cap pharmaceutical company trading in the penny stock category. With a market capitalization of just ₹30 Cr and 100% retail shareholding, the stock falls under the high-risk speculative segment.
In this article, we analyze Johnson Pharmacare Ltd Share Price Target from 2026 to 2030 based on current market data, trading activity, valuation metrics, and sector outlook.
| Detail | Value |
|---|---|
| Open | ₹0.54 |
| Previous Close | ₹0.54 |
| Day’s High | ₹0.55 |
| Day’s Low | ₹0.54 |
| VWAP | ₹0.54 |
| 52-Week High | ₹1.10 |
| 52-Week Low | ₹0.50 |
| All-Time High | ₹210.18 |
| All-Time Low | ₹0.36 |
| Market Capitalization | ₹30 Cr |
| Volume | 4,29,493 |
| Value (Lacs) | ₹2.36 |
| 20D Avg Volume | 9,32,953 |
| 20D Avg Delivery (%) | 65.06% |
| Face Value | ₹1 |
| Book Value Per Share | ₹1.02 |
| UC Limit | ₹0.64 |
| LC Limit | ₹0.44 |
| Beta | 0.41 |
The stock is currently trading close to its 52-week low, indicating weak momentum but potential for speculative bounce.
Johnson Pharmacare Ltd operates in the pharmaceutical segment. However, being a micro-cap company, detailed operational scale and financial strength appear limited compared to established pharma players.
The Indian pharmaceutical industry remains structurally strong due to:
Growing domestic healthcare demand
Export opportunities
Government healthcare initiatives
Generic drug manufacturing strength
However, micro-cap pharma companies often face challenges such as limited product portfolios, regulatory risks, and capital constraints.
| Investor Type | Holding (%) |
|---|---|
| Retail & Others | 100.00% |
The absence of promoter and institutional holding is a major risk factor. Complete retail ownership indicates speculative participation rather than long-term institutional confidence.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2026 | 0.65 | 0.85 |
| 2027 | 0.90 | 1.20 |
| 2028 | 1.30 | 1.80 |
| 2029 | 2.00 | 2.80 |
| 2030 | 3.00 | 4.50 |
⚠️ These projections are highly speculative and depend on business revival, financial improvement, and broader small-cap market cycles.
Potential drivers:
Improved trading volume
Short-term speculative rally
Positive pharma sector sentiment
Investment View: Suitable only for high-risk traders.
If the company shows revenue improvement:
Crossing ₹1 may attract fresh retail interest
Better liquidity in stock
Investment View: Volatile but tradable during bullish cycles.
Growth would require:
Strong financial turnaround
Better operational visibility
Reduced losses or profit generation
Without fundamentals, sustained growth may be difficult.
In strong small-cap bull markets, penny stocks often witness sharp rallies. However, sustainability depends on earnings.
To reach these levels, the company must:
Strengthen balance sheet
Increase promoter confidence
Attract institutional investors
Improve revenue and profitability
Otherwise, growth remains speculative.
Market Cap: ₹30 Cr (Micro-cap)
Book Value: ₹1.02 (Stock trading below book value)
Beta: 0.41 (Low volatility relative to many penny stocks)
52-Week Range: ₹0.50 – ₹1.10
Trading below book value may indicate undervaluation, but only if financials are stable.
100% retail holding (no institutional support)
Penny stock volatility
Limited transparency
Liquidity risk
High downside potential
Micro-cap pharma stocks can offer multi-bagger returns but also carry risk of capital erosion.
Johnson Pharmacare Ltd is a highly speculative penny stock. It may suit:
High-risk traders
Short-term momentum players
Investors allocating very small capital to speculative bets
It is not suitable for conservative or long-term wealth-building portfolios without visible turnaround signs.
Johnson Pharmacare Ltd trades near its 52-week low with a small market cap of ₹30 Cr and 100% retail ownership. While trading below book value may attract value seekers, lack of institutional confidence and limited operational visibility raise concerns.
If the company achieves financial turnaround and benefits from pharma sector growth, the stock could potentially reach ₹3 to ₹4.50 by 2030. However, investors must approach with extreme caution.
1. What is the current share price of Johnson Pharmacare Ltd?
It is trading around ₹0.54 as per recent data.
2. What is the 2026 share price target?
The projected range is ₹0.65 to ₹0.85.
3. What is the 2030 share price target?
The estimated range is ₹3.00 to ₹4.50 (highly speculative).
4. Is Johnson Pharmacare Ltd a safe investment?
No, it is a high-risk micro-cap stock.
5. Why is 100% retail holding risky?
It indicates absence of promoter or institutional confidence, increasing volatility and risk.
Disclaimer: This article is for educational purposes only. Penny stocks carry high risk. Please consult a certified financial advisor before making investment decisions.
Register & Login